Hide Board Information

Show Board Information

Astellas Pharma Inc ALPMF

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/08/2014 6:39:53 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Astellas Pharma Inc (OTCMRKTS: ALPMF) Stock Message Board

1. ALPMF Company Profile

    

2. ALPMF Time & Sales

    

3. ALPMF Recent News

    

4. ALPMF Filings

    

5. ALPMF Financials

    

6. ALPMF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	Latest Astellas Pharma Inc (ALPMF) Headlines	Stock_Tracker	03/08/2014 6:39:53 PM
4	ALPMF 61.69 Stock Charts $ALPMF 1 Month Chart	chartguy89	03/05/2014 9:00:52 PM
3	ALPMF Recent News Astellas Secures Exclusive	Stock_Tracker	03/02/2014 11:39:48 AM
2	ALPMF Stock Charts Saturday, February 22, 2014 at	chartguy89	02/22/2014 7:49:55 AM
1	ALPMF Stock Chart 60.97 Saturday, February 8,	chartguy89	02/08/2014 3:59:57 AM

Recent Articles

• Exciting Announcement: Dycom Industries Q2 2026 Call Details
• Rogers Sugar Inc. Holds Important Call for Q3 Insights
• Altus Group Declares Q3 Dividend Enhancing Shareholder Value
• Tempus AI, Inc. Class Action Lawsuit: Important Investor Alerts
• Discover the Exciting New Features of Bybit Web3
• Assembly Biosciences Secures $175 Million from Equity Financing
• Brown Plus Elevates Courtney Catlin to Learning Manager Role
• Investment Insights: Featured Stocks from CNBC's Analysis
• Jennmar's Strategic Move: Acquiring Weber Mining to Enhance Solutions
• Accel-KKR Announces $1.9 Billion Fund for isolved Growth
• Embick Enterprises, Inc. Extends Roofing Services in Florida
• Explore the 2026 Dodge Durango SRT Hellcat Jailbreak Options
• Targa Invites Investors to Join Private Placement for Growth
• CODIT Unveils Innovative AI Policy Solutions at APEC Forum
• The Alkaline Water Company Achieves Key Audit Success for Uplisting
• Trulieve Cannabis Corp. Unveils Upcoming Event Plans
• Revolutionizing News Access: LG Channels' User-Centric Approach
• CSL's ANDEMBRY® Receives Health Canada Approval for HAE Care
• Gregory M. Yaffa Achieves Fellowship in Trial Law Recognition
• AMETEK Announces Quarterly Dividend for Shareholders
• Telephone and Data Systems Declares Q3 Dividends for 2025
• Equinix Leadership Set to Engage Investors at Key Conferences
• Craveworthy Brands Partners with Gregorys Coffee for Growth
• Explore Metallus's Q2 2025 Earnings Call and Insights
• HOPE Therapeutics Achieves Major Step Forward with Dura Medical
• Community Meeting in Harlem: Addressing Legionnaires' Disease
• Tripadvisor's Upcoming Investor Conferences and Key Insights
• Embick Enterprises Expands Roofer Services in South Florida
• Bitcoin Stabilizes Over $116K, Altcoins Gaining Ground Amid ETF Momentum
• Unlocking Human Potential: The Vision Behind Quantularity
• Boralex Shifts Leadership as CFO Bruno Guilmette Departs
• Terra Balcanica Takes a Major Step with OTCQB Listing
• Strategic Leadership Changes at Boralex with André Courville
• Challenges Ahead: Pyxis Tankers Reports Q2 Performance
• Heron Therapeutics Implements Strategic Capital Changes for Future
• Gauzy Ltd. Welcomes Alejandro Weinstein Back to the Board
• Spectral Medical Provides Insights on Financial Growth and Updates
• Alpha Metallurgical Resources Reports Strong Q2 Financials
• Fiera Capital 2025 Q2 Highlights Showcase Strong Performance
• Sotera Health's Financial Performance Shines in 2025 First Half
• Boralex's Insights on Q2 Performance and Future Growth Plans
• Heron Therapeutics Reports Impressive Q2 2025 Results
• Exploring Blockchain's Future at the Upcoming London Conference
• Heron Therapeutics Unveils Strategic Capital Restructuring Plan
• Heron Therapeutics Reports Robust Growth in Q2 Financials
• Opportunities for Investors Amid Hims & Hers Lawsuit Developments
• Boralex's 2025 Q2 Financial Insights and Future Prospects
• Boralex Welcomes André Courville as New Board Chair
• Boralex's CFO Departure Marks a New Chapter for the Company
• Spectral Medical Reveals Impressive Second Quarter Results